Closing the gap on drug-induced liver injury

Hepatology

Volumn 56, Issue 2, 2012, Pages 781-783

  Maurel, Marion ^a   Rosenbaum, Jean ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 32; N ACETYL 1,4 BENZOQUINONE IMINE; PARACETAMOL; THIOACETAMIDE;

CELL COMMUNICATION; DRUG INTOXICATION; DRUG SAFETY; FATALITY; FULMINANT HEPATIC FAILURE; GAP JUNCTION; LIVER INJURY; LIVER PROTECTION; NONHUMAN; NOTE; OXIDATIVE STRESS; PRIORITY JOURNAL; TOXIC HEPATITIS;

EID: 84864370670     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.25779     Document Type: Note

References (14)

1. Lee WM. Drug-induced hepatotoxicity. N Engl J Med 2003; 349: 474-485.
2. Wysowski DK, Swartz L. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions. Arch Intern Med 2005; 165: 1363-1369.
3. Tujios S, Fontana RJ. Mechanisms of drug-induced liver injury: from bedside to bench. Nat Rev Gastroenterol Hepatol 2011; 8: 202-211.
4. Asamoto M, Hokaiwado N, Murasaki T, Shirai T. Connexin 32 dominant-negative mutant transgenic rats are resistant to hepatic damage by chemicals. HEPATOLOGY 2004; 40: 205-210.
5. Naiki-Ito A, Asamoto M, Naiki T, Ogawa K, Takahashi S, Sato S, et al. Gap junction dysfunction reduces acetaminophen hepatotoxicity with impact on apoptotic signaling and connexin 43 protein induction in rat. Toxicol Pathol 2010; 38: 280-286.
6. Patel SJ, Milwid JM, King KR, Bohr S, Iracheta-Velle A, Li M, et al. Gap junction inhibition prevents drug-induced liver toxicity and fulminant hepatic failure. Nat Biotechnol 2012; 30: 179-183.
7. Jaeschke H, Gores GJ, Cederbaum AI, Hinson JA, Pessayre D, Lemasters JJ. Mechanisms of hepatotoxicity. Toxicol Sci 2002; 65: 166-176.
8. Ferret PJ, Hammoud R, Tulliez M, Tran A, Trebeden H, Jaffray P, et al. Detoxification of reactive oxygen species by a nonpeptidyl mimic of superoxide dismutase cures acetaminophen-induced acute liver failure in the mouse. HEPATOLOGY 2001; 33: 1173-1180.
9. Maruyama T, Kanaji T, Nakade S, Kanno T, Mikoshiba K. 2APB, 2-aminoethoxydiphenyl borate, a membrane-penetrable modulator of Ins(1, 4, 5)P3-induced Ca2+ release. J Biochem 1997; 122: 498-505.
10. Hu HZ, Gu Q, Wang C, Colton CK, Tang J, Kinoshita-Kawada M, et al. 2-aminoethoxydiphenyl borate is a common activator of TRPV1, TRPV2, and TRPV3. J Biol Chem 2004; 279: 35741-35748.
11. Tao L, Harris AL. 2-aminoethoxydiphenyl borate directly inhibits channels composed of connexin26 and/or connexin32. Mol Pharmacol 2007; 71: 570-579.
12. Decrock E, Vinken M, De Vuyst E, Krysko DV, D'Herde K, Vanhaecke T, et al. Connexin-related signaling in cell death: to live or let die? Cell Death Differ 2009; 16: 524-536.
13. Saez JC, Bennett MV, Spray DC. Carbon tetrachloride at hepatotoxic levels blocks reversibly gap junctions between rat hepatocytes. Science 1987; 236: 967-969.
14. Miyashita T, Takeda A, Iwai M, Shimazu T. Single administration of hepatotoxic chemicals transiently decreases the gap-junction-protein levels of connexin 32 in rat liver. Eur J Biochem 1991; 196: 37-42.